Australia markets closed

VRTX Jul 2023 390.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.3500-1.3000 (-49.06%)
At close: 03:33PM EDT
Full screen
Previous close2.6500
Expiry date2023-07-21
Day's range1.3500 - 1.3500
Contract rangeN/A
Open interest2
  • Zacks

    Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound?

    Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    This Cathie Wood Stock Could Nearly Double, According to Wall Street

    One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP). This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in the Ark Genomic Revolution ETF, an exchange-traded fund overseen by Cathie Wood. Wood isn't the only one on Wall Street who likes CRISPR.

  • Motley Fool

    This Is My Highest-Conviction Stock to Own in 2023 and Beyond

    While one could say the same about many biotech companies, Vertex has an advantage very few of its peers do: For CF patients, it's the only game in town. Vertex markets the only medicines that target the underlying causes of CF. In 2022, the company's revenue of $8.93 billion jumped by 18% year over year.